Resultados globales: 6 registros encontrados en 0.02 segundos.
Artículos, Encontrados 6 registros
Artículos Encontrados 6 registros  
1.
12 p, 2.4 MB Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers / Page, Elizabeth C. (Institute of Cancer Research) ; Bancroft, Elizabeth K. (Royal Marsden NHS Foundation Trust) ; Brook, Mark N. (Institute of Cancer Research) ; Assel, Melissa (Memorial Sloan Kettering Cancer Center) ; Hassan Al Battat, Mona (Lund University) ; Thomas, Sarah (Royal Marsden NHS Foundation Trust) ; Taylor, Natalie (Royal Marsden NHS Foundation Trust) ; Chamberlain, Anthony (Institute of Cancer Research) ; Pope, Jennifer (Institute of Cancer Research) ; Raghallaigh, Holly Ni (Institute of Cancer Research) ; Evans, D.Gareth (Central Manchester University Hospitals NHS Foundation Trust) ; Rothwell, Jeanette (Central Manchester University Hospitals NHS Foundation Trust) ; Maehle, Lovise (Oslo University Hospital (Oslo, Noruega)) ; Grindedal, Eli Marie (Oslo University Hospital (Oslo, Noruega)) ; James, Paul (The Royal Melbourne Hospital) ; Mascarenhas, Lyon (Peter MacCallum Cancer Centre) ; McKinley, Joanne (Peter MacCallum Cancer Centre) ; Side, Lucy (Princess Anne Hospital) ; Thomas, Tessy (Princess Anne Hospital) ; van Asperen, Christi (Leiden University Medical Center) ; Vasen, Hans (The Foundation for the Detection of Hereditary Cancer) ; Kiemeney, Lambertus A. (Radboud University Medical Center) ; Ringelberg, Janneke (The Foundation for the Detection of Hereditary Cancer) ; Jensen, Thomas Dyrso. (Vejle Hospital) ; Osther, Palle J.S. (Vejle Hospital) ; Helfand, Brian T. (NorthShore University HealthSystem) ; Genova, Elena (NorthShore University HealthSystem) ; Oldenburg, Rogier A. (Erasmus University Medical Center) ; Cybulski, Cezary (Pomeranian Medical University in Szczecin) ; Wokolorczyk, Dominika (Pomeranian Medical University in Szczecin) ; Ong, Kai-Ren (Birmingham Women's Hospital) ; Huber, Camilla (Birmingham Women's Hospital) ; Lam, Jimmy (Bedford Park) ; Taylor, Louise (Daw Park) ; Salinas, Monica (Hospital Universitari de Bellvitge) ; Feliubadaló, Lidia (Hospital Universitari de Bellvitge) ; Oosterwijk, Jan C. (University of Groningen) ; van Zelst-Stams, Wendy (Radboud University Medical Center) ; Cook, Jackie (Sheffield Children's Hospital (Sheffield, Regne Unit)) ; Rosario, Derek J. (Royal Hallamshire Hospital) ; Domchek, Susan (Basser Research Center. University of Pennsylvania) ; Powers, Jacquelyn (University of Pennsylvania) ; Buys, Saundra (University of Utah) ; O'Toole, Karen (University of Utah) ; Ausems, Margreet G. E. M (University Medical Centre) ; Schmutzler, Rita K. (University Hospital Cologne) ; Rhiem, Kerstin (University Hospital Cologne) ; Izatt, Louise (Guy's and St Thomas' NHS Foundation Trust) ; Tripathi, Vishakha (Guy's and St Thomas' NHS Foundation Trust) ; Teixeira, Manuel R. (Porto University) ; Cardoso, Marta (Portuguese Oncology Institute (IPO Porto)) ; Foulkes, William D. (McGill University, Departments of Human Genetics and Oncology) ; Aprikian, Armen (Research Institute of McGill University Health Centre) ; van Randeraad, Heleen (The Foundation for the Detection of Hereditary Cancer) ; Davidson, Rosemarie (Queen Elizabeth University Hospital) ; Longmuir, Mark (Queen Elizabeth University Hospital) ; Ruijs, Marielle W.G. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; Helderman van den Enden, Apollonia T.J.M. (Maastricht University Medical Center) ; Adank, Muriel (Amsterdam UMC) ; Williams, Rachel (Prince of Wales Hospital (Australia)) ; Andrews, Lesley (Prince of Wales Hospital (Australia)) ; Murphy, Declan G. (Peter MacCallum Cancer Centre) ; Halliday, Dorothy (Oxford Centre for Genomic Medicine) ; Walker, Lisa (Oxford Centre for Genomic Medicine) ; Liljegren, Annelie (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Carlsson, Stefan (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Azzabi, Ashraf (Newcastle upon Tyne Hospitals) ; Jobson, Irene (Newcastle upon Tyne Hospitals) ; Morton, Catherine (The Royal Melbourne Hospital) ; Shackleton, Kylie (The Royal Melbourne Hospital) ; Snape, Katie (St George's Hospital) ; Hanson, Helen (St George's Hospital) ; Harris, Marion (Monash Health) ; Tischkowitz, Marc (University of Cambridge) ; Taylor, Amy (Cambridge University Hospitals NHS Trust) ; Kirk, Judy (Sydney Medical School) ; Susman, Rachel (Royal Brisbane & Women's Hospital) ; Chen-Shtoyerman, Rakefet (Kaplan Medical Center) ; Spigelman, Allan (The Kinghorn Cancer Centre. St Vincent's Hospital) ; Pachter, Nicholas (University of Western Australia) ; Ahmed, Munaza (NE Thames Regional Genetics Service) ; Ramon y Cajal, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Zgajnar, Janez (Institute of Oncology) ; Brewer, Carole (Royal Devon and Exeter Hospital) ; Gadea, Neus (Hospital Universitari Vall d'Hebron) ; Brady, Angela F. (London North West University Healthcare NHS Trust) ; van Os, Theo (Academic Medical Center) ; Gallagher, David (St James's Hospital) ; Johannsson, Oskar (Landspitali University Hospital (Reykjavík, Islàndia)) ; Donaldson, Alan (St Michael's Hospital) ; Barwell, Julian (University Hospitals Leicester) ; Nicolai, Nicola (Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Friedman, Eitan (Chaim Shema Medical Center) ; Obeid, Elias (Fox Chase Cancer Center) ; Greenhalgh, Lynn (Liverpool Women's Hospital) ; Murthy, Vedana (Tata Memorial Centre) ; Copakova, Lucia (National Cancer Institute) ; Saya, Sibel (Institute of Cancer Research) ; McGrath, John (University of Exeter Medical School) ; Cooke, Peter (New Cross Hospital) ; Rønlund, Karina (Vejle Hospital) ; Richardson, Kate (Peter MacCallum Cancer Centre) ; Henderson, Alex (West Cumberland Infirmary) ; Teo, Soo H. (Subang Jaya Medical Centre) ; Arun, Banu (The University of Texas) ; Kast, Karin (Technische Universität Dresden) ; Dias, Alexander (Instituto Nacional de Cancer Jose de Alencar Gomes da Silva (INCA)) ; Aaronson, Neil K (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; Ardern-Jones, Audrey (Royal Marsden NHS Foundation Trust) ; Bangma, Chris H. (Erasmus University Medical Center) ; Castro, Elena (Centro Nacional de Investigaciones Oncológicas) ; Dearnaley, David (The Institute of Cancer Research. Royal Marsden NHS Foundation Trust (Londres, Regne Unit)) ; Eccles, Diana M. (The University of Southampton Medical School) ; Tricker, Karen (Central Manchester University Hospitals NHS Foundation Trust) ; Eyfjord, Jorunn (University of Iceland) ; Falconer, Alison (Imperial College Healthcare NHS Trust) ; Foster, Christopher (HCA Pathology Laboratories) ; Gronberg, Henrik (University Hospital) ; Hamdy, Freddie C. (University of Oxford) ; Stefansdottir, Vigdis (Landspitali University Hospital (Reykjavík, Islàndia)) ; Khoo, Vincent (The University of Melbourne) ; Lindeman, Geoffrey J. (The Walter and Eliza Hall Institute of Medical Research) ; Lubinski, Jan (Pomeranian Medical University in Szczecin) ; Axcrona, Karol (Akershus University Hospital) ; Mikropoulos, Christos (Medway Hospital) ; Mitra, Anita (University College London Hospitals NHS Foundation Trust) ; Moynihan, Clare (Institute of Cancer Research) ; Rennert, Gadi (Carmel Medical Center) ; Suri, Mohnish (Nottingham City Hospital) ; Wilson, Penny (Innovate UK. Polaris House) ; Dudderidge, Tim (University Hospital Southampton) ; Offman, Judith (King's College London) ; Kote-Jarai, Zsofia (Institute of Cancer Research) ; Vickers, Andrew (Memorial Sloan Kettering Cancer Center) ; Lilja, Hans (Memorial Sloan-Kettering Cancer Center (Nova York, Estats Units d'Amèrica)) ; Eeles, Rosalind A. (Royal Marsden NHS Foundation Trust) ; Universitat Autònoma de Barcelona
Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-antigen (PSA) in men with germline BRCA1/2 mutations. [...]
2019 - 10.1016/j.eururo.2019.08.019
European Urology, Vol. 76 Núm. 6 (december 2019) , p. 831-842  
2.
7 p, 214.7 KB Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression / Llibre, Josep M. (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ; Cozzi-Lepri, Alessandro (University College London, UK) ; Pedersen, Court (Odense University Hospital (Dinamarca)) ; Ristola, Matti (Helsinki University Hospital (Finlàndia)) ; Losso, Marcelo (Hospital General de Agudos JM Ramos Mejía, Buenos Aires, Argentina) ; Mocroft, Amanda (University College London, UK) ; Mitsura, Viktar (Gomel State Medical University, Belarus) ; Falconer, Karolin (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Maltez, Fernando (Curry Cabral Hospital, Lisboa, Portugal) ; Beniowski, Marek (Specialistic Hospital, Chorzów, Poland) ; Vullo, Vincenzo (Policlinico Umberto 1, Rome, Italy) ; Hassoun, Gamal (Rambam-Health Care Campus, Haifa, Israel) ; Kuzovatova, Elena (Nizhny Novgorod Scientific and Research Institute of Epidemiology and Microbiology named after Academician I.N. Blokhina, Russia) ; Szlavik, János (St László Hospital (Hongria)) ; Kuznetsova, Anastasiia (Kharkov State Medical University, Ukraine) ; Stellbrink, Hans-Jürgen (ICH Study Center, Hamburg, Germany) ; Duvivier, Claudine (APHP-Hôpital Necker-Enfants Malades, Paris, France) ; Edwards, Simon (Mortimer Market Centre, UK) ; Laut, Kamilla (Centre for Health & University of Copenhagen, Denmark) ; Paredes, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa)
Effectiveness data of an unboosted atazanavir (ATV) with abacavir/lamivudine (ABC/3TC) switch strategy in clinical routine are scant. We evaluated treatment outcomes of ATV + ABC/3TC in pretreated subjects in the EuroSIDA cohort when started with undetectable plasma HIV-1 viral load (pVL), performing a time to loss of virological response (TLOVR <50 copies/mL) and a snapshot analysis at 48, 96, and 144 weeks. [...]
2016 - 10.1097/MD.0000000000005020
Medicine, Vol. 95, Num. 40 (october 2016)  
3.
25 p, 727.1 KB Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19 : a multinational distributed network cohort analysis / Tan, Eng Hooi (Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford) ; Sena, Anthony G. (Department of Medical Informatics, Erasmus University Medical Center (Holanda)) ; Prats-Uribe, Albert (University of Oxford. Centre for Statistics in Medicine) ; You, Seng Chan (Department of Biomedical Informatics, Ajou University School of Medicine (Corea)) ; Ahmed, Waheed-Ul-Rahman (College of Medicine and Health, University of Exeter) ; Kostka, Kristin (Real World Solutions (Estats Units d'Amèrica)) ; Reich, Christian (Real World Solutions (Estats Units d'Amèrica)) ; Duvall, Scott L. (Department of Internal Medicine, University of Utah School of Medicine) ; Lynch, Kristine E. (Department of Internal Medicine, University of Utah School of Medicine) ; Matheny, Michael E. (Department of Biomedical Informatics, Vanderbilt University Medical Center) ; Duarte-Salles, Talita 1985- (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Bertolin, Sergio Fernandez (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Hripcsak, George (New York-Presbyterian Hospital) ; Natarajan, Karthik (New York-Presbyterian Hospital) ; Falconer, Thomas (Columbia University. Department of Biomedical Informatics) ; Spotnitz, Matthew (Columbia University. Department of Biomedical Informatics) ; Ostropolets, Anna (Columbia University. Department of Biomedical Informatics) ; Blacketer, Clair (Department of Medical Informatics, Erasmus University Medical Center (Holanda)) ; Alshammari, Thamir (Medication Safety Research Chair, King Saud Univeristy) ; Alghoul, Heba (Faculty of Medicine, Islamic University of Gaza) ; Alser, Osaid (Massachusetts General Hospital (Boston)) ; Lane, Jennifer C. E. (Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford) ; Dawoud, Dalia M. (Cairo University, Faculty of Pharmacy, Cairo, Egypt) ; Shah, Karishma (Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford) ; Yang, Yue (DHC Technologies) ; Zhang, Lin (Melbourne School of Population and Global Health, The University of Melbourne, Victoria 3015, Australia) ; Areia, Carlos (Nuffield Department of Clinical Neurosciences, University of Oxford) ; Golozar, Asieh (Departament of Epidemiology, Johns Hopkins School of Public) ; Relcade, Martina (Universitat Autònoma de Barcelona) ; Casajust, Paula (Trial Form Support (Barcelona)) ; Jonnagaddala, Jitendra (School of Public Health and Community Medicine (Austràlia)) ; Subbian, Vignesh (College of Engineering, The University of Arizona Tucson) ; Vizcaya, David (Bayer Pharmaceuticals (Barcelona)) ; Lai, Lana Y. H. (School of Medical Sciences, University of Manchester) ; Nyberg, Fredrik (School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg (Suècia)) ; Morales, Daniel R. (Division of Population Health Sciences, University of Dundee) ; Posada, Jose D. (Stanford Center for Biomedical Informatics Research, Department of Medicine, School of Medicine, Stanford University) ; Shah, Nigam H. (Stanford Center for Biomedical Informatics Research, Department of Medicine, School of Medicine, Stanford University) ; Gong, Mengchun (Health Management Institute, Southern Medical University) ; Vivekanantham, Arani (Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford) ; Abend, Aaron (Autoimmune Registry (Regne Unit)) ; Minty, Evan P. (O'Brien School for Public Health, Faculty of Medicine, University of Calgary) ; Suchard, Marc (Department of Biostatistics, University of California) ; Rijnbeek, Peter (Department of Medical Informatics, Erasmus University Medical Center (Holanda)) ; Ryan, Patrick B. (Department of Biomedical Informatics, Columbia University) ; Prieto-Alhambra, Daniel (Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford) ; Universitat Autònoma de Barcelona
Patients with autoimmune diseases were advised to shield to avoid COVID-19, but information on their prognosis is lacking. We characterised 30-day outcomes and mortality after hospitalisation with COVID-19 among patients with prevalent autoimmune diseases, and compared outcomes after hospital admissions among similar patients with seasonal influenza. [...]
2020 - 10.1101/2020.11.24.20236802
medRxiv, november 2020  
4.
14 p, 1007.9 KB A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT) : initial results from an international prospective study / Bancroft, Elizabeth K. (Royal Marsden NHS Foundation Trust, London) ; Page, Elizabeth C. (Institute of Cancer Research, London) ; Brook, Mark N. (Institute of Cancer Research, London) ; Thomas, Sarah (Royal Marsden NHS Foundation Trust, London) ; Taylor, Natalie (Royal Marsden NHS Foundation Trust, London) ; Pope, Jennifer (Institute of Cancer Research, London) ; McHugh, Jana (Institute of Cancer Research, London) ; Jones, Ann-Britt (Institute of Cancer Research, London) ; Karlsson, Questa (Institute of Cancer Research, London) ; Merson, Susan (Institute of Cancer Research, London) ; Ong, Kai Ren (Birmingham Women's Hospital) ; Hoffman, Jonathan (Birmingham Women's Hospital) ; Huber, Camilla (Birmingham Women's Hospital) ; Maehle, Lovise (Oslo University Hospital (Oslo, Noruega)) ; Grindedal, Eli Marie (Oslo University Hospital (Oslo, Noruega)) ; Stormorken, Astrid (Oslo University Hospital (Oslo, Noruega)) ; Evans, Gareth (University of Mancheste) ; Rothwell, Jeanette (University of Manchester) ; Lalloo, Fiona (University of Manchester) ; Brady, Angela F. (London North West University Healthcare NHS Trust, Harrow) ; Bartlett, Marion (London North West University Healthcare NHS Trust, Harrow) ; Snape, Katie (St George's Hospital, Tooting, London) ; Hanson, Helen (St George's Hospital, Tooting, London) ; James, Paul (The University of Melbourne) ; McKinley, Joanne (Parkville Familial Cancer Centre, Melbourne) ; Mascarenhas, Lyon (Parkville Familial Cancer Centre, Melbourne) ; Syngal, Sapna (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Ukaegbu, Chinedu (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Side, Lucy (Wessex Princess Anne Hospital, Southampton) ; Thomas, Tessy (Princess Anne Hospital, Southampton) ; Barwell, Julian (University Hospitals Leicester, Leicester) ; Teixeira, Manuel R. (Porto University, Porto) ; Izatt, Louise (Guy's and St Thomas' NHS Foundation Trust, London) ; Suri, Mohnish (Nottingham University Hospitals NHS Trust (Regne Unit)) ; Macrae, Finlay A. (Royal Melbourne Hospital (Melbourne, Austràlia)) ; Poplawski, Nicola (University of Adelaide, Adelaide) ; Chen-Shtoyerman, Rakefet (Ariel University, Ariel) ; Ahmed, Munaza (Institute of Child Health, London) ; Musgrave, Hannah (Leeds Teaching Hospitals NHS Trust, Leeds) ; Nicolai, Nicola (Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Greenhalgh, Lynn (Clinical Genetics Service, Liverpool Women's Hospital, Liverpool) ; Brewer, Carole (Royal Devon & Exeter Hospital (Exeter, Regne Unit)) ; Pachter, Nicholas (University of Western Australia, Perth) ; Spigelman, Allan D. (St Vincent's Hospital (Sydney)) ; Azzabi, Ashraf (Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne) ; Helfand, Brian T. (NorthShore University HealthSystem, Evanston) ; Halliday, Dorothy (Oxford University Hospitals NHS Trust) ; Buys, Saundra (University of Utah, Salt Lake City) ; Ramon y Cajal, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Donaldson, Alan (St Michael's Hospital, Bristol) ; Cooney, Kathleen A. (Duke Cancer Institute and Duke University School of Medicine, Durham) ; Harris, Marion (Monash University, Clayton) ; McGrath, John (University of Exeter Medical School, Exeter) ; Davidson, Rosemarie (Queen Elizabeth University Hospital, Glasgow) ; Taylor, Amy (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ; Cooke, Peter (New Cross Hospital, Wolverhampton, UK) ; Myhill, Kathryn (Royal Marsden NHS Foundation Trust, London) ; Hogben, Matthew (Royal Marsden NHS Foundation Trust, London) ; Aaronson, Neil K. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; Ardern-Jones, Audrey (Royal Marsden NHS Foundation Trust, London) ; Bangma, Chris H. (Erasmus Cancer Institute, Rotterdam) ; Castro, Elena (Centro Nacional de Investigaciones Oncológicas) ; Dearnaley, David (The Institute of Cancer Research, Sutton) ; Dias, Alexander (Instituto Nacional de Cancer Jose de Alencar Gomes da Silva INCA, Rio de Janeiro) ; Dudderidge, Tim (University Hospital Southampton) ; Eccles, Diana M. (University of Southampton, Southampton) ; Green, Kate (University of Manchester, Manchester) ; Eyfjord, Jorunn (University of Iceland, Reykjavik) ; Falconer, Alison (Imperial College Healthcare NHS Trust, London) ; Foster, Christopher S. (HCA Pathology Laboratories, London) ; Gronberg, Henrik (University Hospital of Umeå) ; Hamdy, Freddie C. (University of Oxford) ; Johannsson, Oskar (Landspitali University Hospital (Reykjavík, Islàndia)) ; Khoo, Vincent (The Institute of Cancer Research, Sutton, Surrey) ; Lilja, Hans (Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York) ; Lindeman, Geoffrey J. (The Walter and Eliza Hall Institute of Medical Research, Parkville) ; Lubinski, Jan (Pomeranian Medical University in Szczecin) ; Axcrona, Karol (Department of Urology, Akershus University Hospital, Lørenskog) ; Mikropoulos, Christos (Royal Surrey County Hospital, Guildford) ; Mitra, Anita V (University College London Hospitals NHS Foundation Trust, London) ; Moynihan, Clare (Institute of Cancer Research, London) ; Ni Raghallaigh, Holly (Institute of Cancer Research, London) ; Rennert, Gad (CHS National Cancer Control Center, Haifa) ; Collier, Rebecca (Nottingham University Hospitals NHS Trust (Regne Unit)) ; Offman, Judith (King's College London) ; Kote-Jarai, Zsofia (Institute of Cancer Research) ; Eeles, Rosalind A. (Royal Marsden NHS Foundation Trust, London) ; Universitat Autònoma de Barcelona
Lynch syndrome is a rare familial cancer syndrome caused by pathogenic variants in the mismatch repair genes MLH1, MSH2, MSH6, or PMS2, that cause predisposition to various cancers, predominantly colorectal and endometrial cancer. [...]
2021 - 10.1016/S1470-2045(21)00522-2
The Lancet. Oncology, Vol. 22 (november 2021) , p. 1618-1631  
5.
11 p, 2.3 MB Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom / Recalde, Martina (Universitat Autònoma de Barcelona) ; Roel, Elena (Universitat Autònoma de Barcelona) ; Pistillo, Andrea (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Sena, Anthony G. (Erasmus University Medical Center. Department of Medical Informatics) ; Prats-Uribe, Albert (University of Oxford. Centre for Statistics in Medicine) ; Ahmed, Waheed-Ul-Rahman (University of Exeter. College of Medicine and Health) ; Alghoul, Heba (Islamic University of Gaza. Faculty of Medicine) ; Alshammari, Thamir (Riyadh Elm University. College of Pharmacy) ; Alser, Osaid (Harvard Medical School) ; Areia, Carlos (University of Oxford. Nuffield Department of Clinical Neurosciences) ; Burn, Edward (University of Oxford. Centre for Statistics in Medicine) ; Casajust, Paula (Trial Form Support (Barcelona, Catalunya)) ; Dawoud, Dalia (Cairo University. Faculty of Pharmacy) ; DuVall, Scott L. (University of Utah School of Medicine. Department of Internal Medicine) ; Falconer, Thomas (Columbia University. Department of Biomedical Informatics) ; Fernández-Bertolín, Sergio (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Golozar, Asieh (Regeneron Pharmaceuticals. Pharmacoepidemiology) ; Gong, Mengchun (DHC Technologies) ; Lai, Lana Yin Hui (University of Manchester. Division of Cancer Sciences) ; Lane, Jennifer C. E. (University of Oxford. Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences) ; Lynch, Kristine E. (University of Utah School of Medicine. Department of Internal Medicine) ; Matheny, Michael E. (Vanderbilt University Medical Center. Department of Biomedical Informatics) ; Mehta, Paras P. (The University of Arizona. College of Medicine) ; Morales, Daniel R. (University of Dundee. Division of Population Health and Genomics) ; Natarjan, Karthik (New York-Presbyterian Hospital) ; Nyberg, Fredrik (University of Gothenburg. Institute of Medicine) ; Posada, Jose D. (Stanford University. Department of Medicine) ; Reich, Christian G. (Real World Solutions) ; Rijnbeek, Peter R. (Erasmus University Medical Center. Department of Medical Informatics) ; Schilling, Lisa M. (University of Colorado Anschutz Medical Campus. Department of Medicine) ; Shah, Karishma (University of Oxford. Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences) ; Shah, Nigam H. (Stanford University. Department of Medicine) ; Subbian, Vignesh (The University of Arizona. College of Engineering) ; Zhang, Lin (The University of Melbourne. Melbourne School of Population and Global Health) ; Zhu, Hong (Southern Medical University. Nanfang Hospital) ; Ryan, Patrick (Columbia University. Department of Biomedical Informatics) ; Prieto-Alhambra, Daniel (University of Oxford. Centre for Statistics in Medicine) ; Kostka, Kristin (Northeastern University. The OHDSI Center at the Roux Institute) ; Duarte-Salles, Talita 1985- (Institut Universitari d'Investigació en Atenció Primària Jordi Gol)
A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to those of patients living without obesity. [...]
2021 - 10.1038/s41366-021-00893-4
International Journal of Obesity, Vol. 45 (july 2021) , p. 2347-2357  
6.
28 p, 649.1 KB COVID-19 in patients with autoimmune diseases : characteristics and outcomes in a multinational network of cohorts across three countries / Tan, Eng Hooi (University of Oxford. Centre for Statistics in Medicine) ; Sena, Anthony G. (Erasmus University Medical Center) ; Prats-Uribe, Albert (University of Oxford. Centre for Statistics in Medicine) ; You, Seng Chan (Suwon) ; Ahmed, Waheed-Ul-Rahman (University of Exeter) ; Kostka, Kristin (Real World Solutions) ; Reich, Christian (Real World Solutions) ; Duvall, Scott L. (Salt Lake City) ; Lynch, Kristine E. (Salt Lake City) ; Matheny, Michael E. (Vanderbilt University Medical Center) ; Duarte-Salles, Talita 1985- (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Bertolin, Sergio Fernandez (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Hripcsak, George (New York-Presbyterian Hospital) ; Natarajan, Karthik (New York-Presbyterian Hospital) ; Falconer, Thomas (Columbia University. Department of Biomedical Informatics) ; Spotnitz, Matthew (Columbia University) ; Ostropolets, Anna (Columbia University) ; Blacketer, Clair (Erasmus University Medical Center) ; Alshammari, Thamir (King Saud Univeristy. Medication Safety Research Chair) ; Alghoul, Heba (Islamic University of Gaza) ; Alser, Osaid (Harvard Medical School) ; Lane, Jennifer C. E. (University of Oxford. Centre for Statistics in Medicine) ; Dawoud, Dalia M. (Cairo University) ; Shah, Karishma (University of Oxford. Botnar Research Centre) ; Yang, Yue (DHC Technologies Co) ; Zhang, Lin (The University of Melbourne) ; Areia, Carlos (University of Oxford) ; Golozar, Asieh (Departament of Epidemiology) ; Recalde, Martina (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Casajust, Paula (Real-World Evidence) ; Jonnagaddala, Jitendra (UNSW Sydney) ; Subbian, Vignesh (The University of Arizona Tucson) ; Vizcaya, David (Bayer Pharmaceuticals) ; Lai, Lana Y H. (University of Manchester) ; Nyberg, Fredrik (University of Gothenburg. Institute of Medicine) ; Morales, Daniel R. (University of Dundee) ; Posada, Jose D. (Stanford University. Stanford Center for Biomedical Informatics Research) ; Shah, Nigam H. (Stanford University. Stanford Center for Biomedical Informatics Research) ; Gong, Mengchun (Southern Medical University. Health Management Institute) ; Vivekanantham, Arani (University of Oxford. Botnar Research Centre) ; Abend, Aaron (Autoimmune Registry Inc) ; Minty, Evan P. (University of Calgary. O'Brien School for Public Health) ; Suchard, Marc (University of California) ; Rijnbeek, Peter (Erasmus University Medical Center) ; Ryan, Patrick B. (Columbia University) ; Prieto-Alhambra, Daniel (University of Oxford. Centre for Statistics in Medicine) ; Universitat Autònoma de Barcelona
Patients with autoimmune diseases were advised to shield to avoid COVID-19, but information on their prognosis is lacking. We characterised 30-day outcomes and mortality after hospitalisation with COVID-19 among patients with prevalent autoimmune diseases, and compared outcomes after hospital admissions among similar patients with seasonal influenza. [...]
2021 - 10.1093/rheumatology/keab250
Rheumatology, march 2021  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.